Greater inclusion of women in surgical trials and reporting of sex-based treatment effects are warranted, they say.

A maladaptive stress response might be amenable to behavioral or other interventions to lower future CV risk, say researchers ...

Obesity influences the thresholds, but even in nonobese patients with dyspnea, optimal cutoffs may be lower than recommended.

Task force members say that continued collection of data will help build credibility of what is “fair market value” for ...

The ability to diagnose MI was better with troponin I, but T better predicted mortality. Both tests have strengths, ...

These latest data reinforce years of smaller studies, but whether they should change practice is a matter of debate.

This year’s report shows risk factors on the rise, enduring racial and geographic gaps, and clues to the global picture, too.

New data from US centers suggest some overtesting in patients without chest pain, and undertesting in those who do.

It’s not yet time to abandon seated BP measurements, but taking a look at supine readings may provide enhanced risk ...

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.

A safety committee will review all evidence from trials and studies to shed more light on the potential risk of NAION.

Much has changed since the 2013 document came out, with new information on pacing devices, techniques, and more.